|
Volcano Corp. Announces
Events at TCT Meeting
IVUS and FFR to be Featured
in Late-Breaking Trials, Seminars and Satellite Symposia
|
 |
IVUS Image
of coronary artery |
|
September
10, 2009 --
Volcano Corporation (Nasdaq: VOLC), a leader in the fields of
Intravascular
Ultrasound (IVUS) and Functional Measurement (FM) today announced
a wide variety of events taking place at this year's Transcatheter
Cardiovascular Therapeutics (TCT) meeting in San Francisco. A
spectrum of activities will demonstrate how these technologies
can improve
the results obtained from angioplasty and stenting,
and includes late-breaking clinical trials, symposia with panels
of experts, live case demonstrations and an investor event. |
The main events are listed below. In addition,
live case demonstrations utilizing IVUS and FM technology will be
ongoing
throughout
the conference.
Wednesday, September 23
6:30-8:00am: Breakfast Symposium
"Right Patient, Right Lesion, Right Way: Healthcare Reform Demands
Precise, Targeted Interventions…Angiography Alone is Not Enough"
Location:
Moscone Center Room 123
Speakers: William J. French, MD; Hoang M. Thai, MD
Breakfast begins at 6:30, with presentations beginning at 7:00am
12:15 pm: Late-Breaking
Clinical Trial
FAME: Two-Year Follow-up from a
Prospective Randomized Trial of FFR-Guided vs.
Angiography-Guided PCI in Patients with
Multivessel Coronary Artery Disease
Location: Esplanade Ballroom (Main Arena)
William F. Fearon, MD
Thursday, September 24
10:30-11:30
am: Investor Event
This event features Dr. Morton Kern discussing “Precision
Guided PCI-FFR and Cost-Effective
Care—Angiography Alone is Not Enough.” In addition, Scott
Huennekens,
President and Chief Executive Officer, will provide a brief update
on the
company. A Q&A session will follow the formal presentations.
Location: St. Regis San Francisco, Collections II (note room change),
125 Third Street
RSVP: Cindy Birse, cbirse@volcanocorp.com, (858)
720-4050.
12:15 pm: Late-Breaking Clinical Trial
PROSPECT: A Natural History Study of
Atherosclerosis Using Multimodality Intracoronary
Imaging to Prospectively Identify Vulnerable
Plaque
Location: Esplanade Ballroom (Main Arena)
Gregg W. Stone, MD
4:00pm: Q&A
Scott Huennekens, President and CEO of Volcano Corporation, will hold
a Q&A
regarding the PROSPECT data
Location: Exhibit Floor, Volcano booth (#411)
7:00-10:00pm: Evening Symposium
"Imaging
Matters!
Identifying High Risk Patients and Optimizing PCI; Late Breaking
Results
From PROSPECT, FAME and More”
Drs. Gregg Stone
and
Patrick Serruys, co-chairs
Dr. Stone will be
discussing, “PROSPECT II: Plaque Characterization Predicts
Future Events,” and Dr. Serruys will be presenting, “Rationale
for Vulnerable Plaque
Detection: Prior Studies and PROSPECT Design."
Location: Hilton San Francisco, Imperial Ballroom
Reception begins at 7 pm, with presentations beginning at 8 pm
Agenda
Session I: Can Imaging Help Identify At-Risk
Vulnerable Plaques and Patients Before the Catastrophe (or
Patients and Lesions Not at Risk)?
8:00 pm Rationale for Vulnerable Plaque Detection:
Prior Studies and PROSPECT
Design
Patrick W. Serruys
8:10 pm PROSPECT I: Imaging Results
Gary S. Mintz
8:20 pm PROSPECT II: Plaque Characterization Predicts Future Events
Gregg W. Stone
8:35 pm PROSPECT III: Image Review and Instructive Case Examples
Alexandra J. Lansky and Gary S. Mintz
8:50 pm Panel Discussion: Identifying Vulnerable (and Non Vulnerable) Plaque
and Vulnerable Patients
Session II: Ischemia, FFR and Optimal Revascularization
9:05 pm The Central Role of Ischemia in Predicting
Prognosis after PCI
Gregg W. Stone
9:15 pm FFR in Intermediate Lesions: From DEFER to FAME
Bernard de Bruyne
9:30 pm Insights from FAME: Which Lesions and Patients Need FFR? Technique
Tips and Tricks
William Fearon
9:45 pm FFR to Guide Patient Care Decisions
and PCI: Instructive Case Examples
Morton J. Kern
9:59 pm Closing Remarks
Gregg W. Stone and Patrick W. Serruys
10:00 pm Adjourn
|
Throughout exhibition hours on Wed-Fri, Volcano will be exhibiting
its full suite of IVUS, FM, OCT & FL IVUS
technologies
at their booth (#411).
(John Dahldorf, Chief Financial Officer,
will be available for one-on-one meetings at the booth, on Friday,
September 25th, through mid-afternoon.
If you would like to schedule a meeting, please contact Neal Rosen
at
rosenn@ruderfinn.com, or (415) 692-3058.)
Source: Volcano
Corporation with additional reporting by Burt Cohen
|
